5-amino-6-(5-phospho-beta-D-ribosylamino)uracil

Term ID

CHEBI:18337

Synonyms

5-Amino-6-(5'-phosphoribosylamino)uracil
5-Amino-6-(5-phosphoribosylamino)uracil
5-Amino-6-(ribosylamino)-2,4-(1H,3H)-pyrimidinedione 5'-phosphate
N-(5-amino-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-5-O-phosphono-beta-D-ribofuranosylamine
N-(5-amino-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-beta-D-ribofuranosylamine 5-(dihydrogen phosphate)

Definition

An N-glycosyl compound that consists of 5,6-diaminouracil in which one of the hydrogens on the 6-amino function is substituted by a 5-phospho-beta-D-ribosyl residue.

References

KEGG:C01268
KNApSAcK:C00019665

Ontology

ChEBI ( EBI )

Relationships

is a type of: aminouracil N-glycosyl compound ribose monophosphate

aminouracil N-glycosyl compound ribose monophosphate Show first 5 Terms
has_role: Escherichia coli metabolite

Escherichia coli metabolite Show first 5 Terms
inverse is_conjugate_base_of: 5-amino-6-(5-phospho-D-ribosylamino)uracil(2-)

5-amino-6-(5-phospho-D-ribosylamino)uracil(2-) Show first 5 Terms
is_conjugate_acid_of: 5-amino-6-(5-phospho-D-ribosylamino)uracil(2-)

5-amino-6-(5-phospho-D-ribosylamino)uracil(2-) Show first 5 Terms

Phenotype

Phenotype resulting from 5-amino-6-(5-phospho-beta-D-ribosylamino)uracil

Phenotype where environments contain 5-amino-6-(5-phospho-beta-D-ribosylamino)uracil

Phenotype modified by environments containing 5-amino-6-(5-phospho-beta-D-ribosylamino)uracil

Human Disease Model